Belite Bio Changes Auditors to Deloitte & Touche
Ticker: BLTE · Form: 6-K · Filed: Mar 28, 2025 · CIK: 1889109
| Field | Detail |
|---|---|
| Company | Belite Bio, INC (BLTE) |
| Form Type | 6-K |
| Filed Date | Mar 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: auditor-change, 6-K
TL;DR
Belite Bio ditches Marcum, brings in Deloitte & Touche as new auditor.
AI Summary
Belite Bio, Inc. announced on March 28, 2025, the dismissal of its former auditor, Marcum Asia CPAs LLP. The company has appointed Deloitte & Touche as its successor auditor, effective the same date.
Why It Matters
A change in auditors can signal a shift in financial reporting scrutiny or strategic direction for the company.
Risk Assessment
Risk Level: low — This filing is a routine change of auditor and does not contain information that inherently increases risk.
Key Players & Entities
- Belite Bio, Inc. (company) — Registrant
- Marcum Asia CPAs LLP (company) — Former Auditor
- Deloitte & Touche (company) — Successor Auditor
- March 28, 2025 (date) — Effective date of auditor change
FAQ
Who was Belite Bio, Inc.'s former auditor?
Belite Bio, Inc.'s former auditor was Marcum Asia CPAs LLP.
Who is Belite Bio, Inc.'s new auditor?
Belite Bio, Inc.'s new auditor is Deloitte & Touche.
When was the change in auditors effective?
The change in auditors was effective March 28, 2025.
What type of filing is this report?
This report is a Form 6-K, a Report of Foreign Private Issuer.
What is Belite Bio, Inc.'s principal executive office address?
Belite Bio, Inc.'s principal executive office is located at 12750 High Bluff Drive Suite 475, San Diego, CA 92130.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 28, 2025 regarding BELITE BIO, INC (BLTE).